NEW YORK (GenomeWeb) – Contextual Genomics today announced that it has received accreditation from the College of American Pathologists.

The Vancouver, Canada-based firm is developing next-generation sequencing-based tumor profiling tests. Last year, it launched a tumor profiling consortium in Canada with the Personalized Medicine Initiative.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.